跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,167 条关于
“SCF E3 ubiquitin ligases”
全部
4,167
临床试验
3,252
药物
646
机构
54
资讯
215
9个月前
Phase I Trial Evaluates Pevonedistat-Capecitabine-Oxaliplatin Combination for Advanced Gastric Cancer
28天前
Identification and Characterization of Mitochondrial E3 Ubiquitin Protein Ligase 1 (MUL1) in Disease Regulation
去年
Nurix Therapeutics Appoints Anil Kapur to Board, Plans Pivotal Trial for NX-5948
去年
Agilent and Ubix Therapeutics Form 5-Year Partnership to Advance Targeted Cancer Therapies in South Korea
11个月前
Frontier Medicines Unveils DCAF2 as Novel E3 Ligase for Targeted Protein Degradation in Cancer Treatment
去年
AbbVie and Neomorph Forge $1.64 Billion Molecular Glue Degrader Partnership for Oncology and Immunology
9个月前
Convergen Raises $10 Million to Advance Novel TrimTAC Platform Targeting Neurodegenerative Disease Protein Aggregates
去年
BPGbio to Unveil Novel E2-Based Targeted Protein Degradation Platform at European Summit
6个月前
Outrun Therapeutics Advances First-in-Class E6AP Inhibitor for HPV-Positive Head and Neck Cancer
10个月前
SEED Therapeutics Receives China NMPA Clearance for ST-01156 Molecular Glue Degrader in Rare Cancer Trial
第 1 页,共 22 页
上一页
下一页